| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 25.05.
| InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to Be Held on May 30th | | 130 | Business Wire |
| InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of
groundbreaking technologies for the treatment
of spinal cord injuries (SCI), today announced that the...
Mehr lesen zu:
InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to Be Held on May 30th | |
| 18.05.
| InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on Austin News Today Weekend and Detroit's 7 Action News This Weekend | | 37 | Business Wire |
| Local Paralyzed Teen to Join Reynolds for Detroit Appearance
InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of
groundbreaking technologies...
Mehr lesen zu:
InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on Austin News Today Weekend and Detroit's 7 Action News This Weekend | |
| 16.05.
| InVivo Therapeutics Chief Science Officer Edward Wirth to Discuss Biopolymers and Hydrogels for SCI at Rick Hansen's Interdependence 2012 | | 26 | Business Wire |
| Global SCI Conference Brings Together Top Research Teams from Around
the World
InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), today
announced...
Mehr lesen zu:
InVivo Therapeutics Chief Science Officer Edward Wirth to Discuss Biopolymers and Hydrogels for SCI at Rick Hansen's Interdependence 2012 | |
| 15.05.
| InVivo Therapeutics Reports First Quarter 2012 Financial Results, Provides Business Update | | 35 | Business Wire |
| InVivo Therapeutics Holdings Corp. (OTCBB:NVIV), a developer of
groundbreaking technologies for the treatment of spinal cord injuries
(SCI), today reported the financial...
Mehr lesen zu:
InVivo Therapeutics Reports First Quarter 2012 Financial Results, Provides Business Update | |
| 11.05.
| InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research | | 49 | Business Wire |
| Jack Harvey and Celina Chang Join InVivo from Pervasis Therapeutics
InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), announced
today the appointment...
Mehr lesen zu:
InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research | |
| 08.05.
| InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on KGO-TV in San Francisco | | 28 | Business Wire |
| CEO to Discuss the Company's Latest Advances on May 9th
InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of
groundbreaking technologies...
Mehr lesen zu:
InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on KGO-TV in San Francisco | |
| 13.04.
| InVivo Therapeutics Expects to Commence Human Study after Meeting on IDE Filing for Biopolymer Scaffolding to Treat Spinal Cord Injuries | | 45 | Business Wire |
| InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of
groundbreaking technologies for the treatment of spinal cord injuries
(SCI), announced today that it...
Mehr lesen zu:
InVivo Therapeutics Expects to Commence Human Study after Meeting on IDE Filing for Biopolymer Scaffolding to Treat Spinal Cord Injuries | |
| 11.04.
| InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on Local TV Affiliates in Charlotte, Indianapolis and Greensboro | | 35 | Business Wire |
| CEO to Discuss the Company's Latest Advances on April 14, 16 and
17, Respectively
InVivo Therapeutics Holdings Corp. (OTCBB: NVIV), a developer of
...
Mehr lesen zu:
InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on Local TV Affiliates in Charlotte, Indianapolis and Greensboro | |
| 15.03.
| InVivo Therapeutics Reports 2011 Financial Results, Provides Business Update | | 28 | Business Wire |
| InVivo Therapeutics Holdings Corp. (OTCBB: NVIV), a developer of
groundbreaking technologies for the treatment of spinal cord injuries
(SCI), today reported the financial...
Mehr lesen zu:
InVivo Therapeutics Reports 2011 Financial Results, Provides Business Update | |
| 13.03.
| InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on Fox 5 News: Live in Las Vegas | | 40 | Business Wire |
| CEO to Discuss the Company's Latest Advances on March 16th
InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of
groundbreaking technologies...
Mehr lesen zu:
InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on Fox 5 News: Live in Las Vegas | |
| 07.03.
| InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on St. Louis' Fox 2 News in the Morning | | 32 | Business Wire |
| CEO to Discuss the Company's Latest Advances in Spinal Cord Injury
Treatment on March 12th
InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer...
Mehr lesen zu:
InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on St. Louis' Fox 2 News in the Morning | |
| 22.02.
| Stryker's 2010 Innovator of the Year Brian Hess Joins InVivo Therapeutics as Director of Product Development | | 49 | Business Wire |
| Moves from Stryker to Translate InVivo's Biomaterials for Acute and
Chronic Neurological Injuries to Market
InVivo Therapeutics Holdings Corp. (OTC/BB:...
Mehr lesen zu:
Stryker's 2010 Innovator of the Year Brian Hess Joins InVivo Therapeutics as Director of Product Development | |
| 22.02.
| InVivo Therapeutics Announces Full Exercise of Over-Allotment Option | | 69 | Business Wire |
| InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of
groundbreaking technologies for the treatment of spinal cord injuries,
today announced the full exercise...
Mehr lesen zu:
InVivo Therapeutics Announces Full Exercise of Over-Allotment Option | |
| 17.02.
| InVivo Therapeutics Announces Pricing of Public Offering of Common Stock | | 95 | Business Wire |
| InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of
groundbreaking technologies for the treatment of spinal cord injuries,
today announced the pricing of...
Mehr lesen zu:
InVivo Therapeutics Announces Pricing of Public Offering of Common Stock | |
| 17.01.
| InVivo Therapeutics, Geisinger Health System to Conduct Preclinical Study of Injectable Scaffold for Peripheral Nerve Injury For FDA Submission | | 60 | Business Wire |
| Research to Provide Foundation for Use of Biocompatible Hydrogel
Therapies Beyond Spinal Cord Injury Treatment
InVivo Therapeutics Holdings Corp. (OTC/BB:...
Mehr lesen zu:
InVivo Therapeutics, Geisinger Health System to Conduct Preclinical Study of Injectable Scaffold for Peripheral Nerve Injury For FDA Submission | |
| 12.01.
| InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on KSTP-TV (ABC) and KMSP-TV (FOX) in Minneapolis To Discuss Paralyzing Injuries To Local High School Hockey Players | | 53 | Business Wire |
| CEO to Discuss the Company's Latest Advances in Spinal Cord Injury
Treatment on January 15th and
January 16th
InVivo Therapeutics Holdings Corp....
Mehr lesen zu:
InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on KSTP-TV (ABC) and KMSP-TV (FOX) in Minneapolis To Discuss Paralyzing Injuries To Local High School Hockey Players | |
| 11.01.
| InVivo Therapeutics to Present at Noble Financial Capital Markets' Eighth Annual BOCEMb Equity Conference | | 31 | Business Wire |
| InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of
groundbreaking technologies for the treatment
of spinal cord injuries (SCI), today announced CEO Frank...
Mehr lesen zu:
InVivo Therapeutics to Present at Noble Financial Capital Markets' Eighth Annual BOCEMb Equity Conference | |
| 10.01.
| InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on FOX40 Live in Sacramento | | 42 | Business Wire |
| CEO to Discuss the Company's Latest Advances in Spinal Cord Injury
Treatment on January 11th
InVivo Therapeutics Holdings Corp. (OTCBB: NVIV), a developer...
Mehr lesen zu:
InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on FOX40 Live in Sacramento | |
| 04.01.
| InVivo Therapeutics to Present at the Fourth Annual BioTech Showcase 2012 | | 23 | Business Wire |
| Company to Showcase Latest Advances in Spinal Cord Injury
Treatment at Industry's Largest Annual Healthcare Investor Conference
InVivo Therapeutics...
Mehr lesen zu:
InVivo Therapeutics to Present at the Fourth Annual BioTech Showcase 2012 | |
| 21.12.
| Clubpennystocks Volume WatchList: ALZM (Allezoe Medical), DROP (Fuse Science), SPAH (Spectrum Acquisition), ABOT (Abot Mining), NVIV (InVivo Therapeutics), AMWI (Amwest), and NOKBF (Nokia Corp) | | 68 | MarketWire |
| LONDON, ENGLAND -- (Marketwire) -- 12/21/11 -- http://www.clubpennystock.com The US leader in micro cap alerts offers its high quality stocks alert newsletter to investors looking for the best picks...
Mehr lesen zu:
Clubpennystocks Volume WatchList: ALZM (Allezoe Medical), DROP (Fuse Science), SPAH (Spectrum Acquisition), ABOT (Abot Mining), NVIV (InVivo Therapeutics), AMWI (Amwest), and NOKBF (Nokia Corp) | |
